CS248743B2 - Production method of the 2-amino-3-ethoxycarbonylamino-6-/p-fluor-benzylamino/-pyridingluconate - Google Patents

Production method of the 2-amino-3-ethoxycarbonylamino-6-/p-fluor-benzylamino/-pyridingluconate Download PDF

Info

Publication number
CS248743B2
CS248743B2 CS853157A CS315785A CS248743B2 CS 248743 B2 CS248743 B2 CS 248743B2 CS 853157 A CS853157 A CS 853157A CS 315785 A CS315785 A CS 315785A CS 248743 B2 CS248743 B2 CS 248743B2
Authority
CS
Czechoslovakia
Prior art keywords
amino
water
ethoxycarbonylamino
solution
gluconic acid
Prior art date
Application number
CS853157A
Other languages
Czech (cs)
English (en)
Inventor
Helmut Hettche
Peter Eming
Juergen Engel
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of CS248743B2 publication Critical patent/CS248743B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10Polyhydroxy carboxylic acids
    • C07C59/105Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS853157A 1984-05-05 1985-04-30 Production method of the 2-amino-3-ethoxycarbonylamino-6-/p-fluor-benzylamino/-pyridingluconate CS248743B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (1)

Publication Number Publication Date
CS248743B2 true CS248743B2 (en) 1987-02-12

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
CS853157A CS248743B2 (en) 1984-05-05 1985-04-30 Production method of the 2-amino-3-ethoxycarbonylamino-6-/p-fluor-benzylamino/-pyridingluconate

Country Status (25)

Country Link
US (1) US4673666A (xx)
EP (1) EP0160865B1 (xx)
JP (1) JPS60239469A (xx)
KR (1) KR850008678A (xx)
AT (1) ATE33638T1 (xx)
AU (1) AU4194385A (xx)
BG (1) BG44537A3 (xx)
CA (1) CA1263398A (xx)
CS (1) CS248743B2 (xx)
DD (1) DD236927A5 (xx)
DE (2) DE3416609A1 (xx)
DK (1) DK157016C (xx)
ES (1) ES542817A0 (xx)
FI (1) FI80443C (xx)
GR (1) GR851065B (xx)
HU (1) HU193753B (xx)
IE (1) IE57766B1 (xx)
IL (1) IL75086A (xx)
MC (1) MC1651A1 (xx)
NO (1) NO851772L (xx)
PL (1) PL253202A1 (xx)
PT (1) PT80386B (xx)
SU (1) SU1398772A3 (xx)
YU (1) YU71785A (xx)
ZA (1) ZA853351B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
EP2350009B1 (en) * 2008-06-09 2016-03-16 TEVA GmbH Sulfonate salts of flupirtine
EA020545B1 (ru) 2008-06-09 2014-12-30 Авд. Фарма Гмбх Унд Ко. Кг Соли карбоновой кислоты 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate

Also Published As

Publication number Publication date
SU1398772A3 (ru) 1988-05-23
DK157016B (da) 1989-10-30
ES8603423A1 (es) 1985-12-16
ES542817A0 (es) 1985-12-16
EP0160865B1 (de) 1988-04-20
IL75086A0 (en) 1985-09-29
IL75086A (en) 1988-03-31
FI851752L (fi) 1985-11-06
BG44537A3 (en) 1988-12-15
DE3562242D1 (en) 1988-05-26
DK198785D0 (da) 1985-05-02
US4673666A (en) 1987-06-16
CA1263398A (en) 1989-11-28
EP0160865A3 (en) 1986-03-12
FI80443C (fi) 1990-06-11
FI851752A0 (fi) 1985-05-03
JPS60239469A (ja) 1985-11-28
DK157016C (da) 1990-03-26
MC1651A1 (fr) 1986-04-07
DK198785A (da) 1985-11-06
ZA853351B (en) 1985-12-24
PT80386A (de) 1985-06-01
YU71785A (en) 1988-02-29
FI80443B (fi) 1990-02-28
JPH0144185B2 (xx) 1989-09-26
NO851772L (no) 1985-11-06
DE3416609A1 (de) 1985-11-07
AU4194385A (en) 1985-11-07
IE57766B1 (en) 1993-03-24
ATE33638T1 (de) 1988-05-15
DD236927A5 (de) 1986-06-25
HU193753B (en) 1987-11-30
HUT37758A (en) 1986-02-28
PL253202A1 (en) 1986-07-15
PT80386B (de) 1987-04-16
KR850008678A (ko) 1985-12-21
GR851065B (xx) 1985-11-25
IE851117L (en) 1985-11-05
EP0160865A2 (de) 1985-11-13

Similar Documents

Publication Publication Date Title
CS248743B2 (en) Production method of the 2-amino-3-ethoxycarbonylamino-6-/p-fluor-benzylamino/-pyridingluconate
US4460590A (en) Diglycidyl substituted heterocyclic compounds
EP0009425B1 (en) Novel naphtyridine derivatives and pharmaceutical compositions containing them
EP0944617B1 (en) Crystals of benzimidazole derivatives and their production
EP1105386B1 (en) Novel salt form of pantoprazole
HU176111B (en) Process for preparing methylthio-naphtimidazole derivatives substituted with a heterocyclic group
DK172077B1 (da) 6-Fluor-7-(4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinolin-3-carboxylsyre-derivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende disse forbindelser
US4426526A (en) Alkoxypyridyl alkylamines
HU193258B (en) Process for preparing piperazine derivatives and acid addition salts thereof
EP0132764B1 (en) Derivatives of dihydrodibenzocycloheptylidene-ethylamine
DK159114B (da) Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser
JPS5822119B2 (ja) ジチオ−ル誘導体
EP1068196A1 (en) Nitrate salt of anti-ulcer medicine
US4154838A (en) Alkoxy pyridine
CZ20014458A3 (cs) Polymorfní formy krystalického (2-benzhydryl-l-azabicyklo[2,2,2]okt-3-yl)-(5-isopropyl-2-methoxybenzyl) amoniumchloridu jako antagonisté receptoru NK-1
KR102413552B1 (ko) 인돌로파이란 유도체 및 이의 합성 방법
US4304914A (en) Naphthyridone derivatives
KR880001281B1 (ko) 9,10-치환된 2-메시틸이미노-3-알킬-3,4,6,7-테트라하이드로-2H-피리미도(6,1-a)이소퀴놀린-4-온의 제조방법
AU6973598A (en) Methods for synthesizing 2-substituted imidazoles
CS198157B2 (en) Process for preparing 2-hydroxymethyl-3-hydoxy-6-/1-hydroxy-2-terc.butylaminoethyl/pyridine and additive salt with acid thereof
HU180716B (en) Process for preparing substituted amino-alkyl-guanidines
KR830002533B1 (ko) 수용성 3-포르밀리파미이신 sv 하이드라존의 제조방법
WO2021216777A1 (en) Erk inhibitors for cancer therapy
MIZUNO et al. Studies on the chemical synthesis of potential antimetabolites. XXIV. The synthesis and antitumor activities of p-tosylhydrazones of 2-formylpyridine 1-oxides and 2-formylazoles 3-oxides
CS332191A3 (en) 2-/2-thienyl/-imidazo/4,5-piridine derivatives and their pharmaceutically acceptable addition salts with acids and process for preparing thereof